Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 1
PBH Forecast
1 other identifier
observational
50
1 country
1
Brief Summary
The overall aim of this study is to prevent hypoglycemic events in patients with hypoglycemia after a meal and to develop a sustainable hypoglycemia correction strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2022
CompletedStudy Start
First participant enrolled
January 18, 2022
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2023
CompletedAugust 23, 2023
August 1, 2023
1.5 years
January 14, 2022
August 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Precision (fraction of correct alarms over the total number of raised alarms) and recall (fraction of correctly predicted hypoglycaemic events over the total number of episodes)
Selecting the best performing hypoglycaemia prediction
10 days
Secondary Outcomes (2)
False alarms
10 days
Time anticipation
10 days
Study Arms (1)
PBH
Interventions
Participants wear a CGM and a smartwatch while keeping an electronic diary with information such as meals, sleep, and activity.
Eligibility Criteria
The study population consists of post-bariatric patients with PBH.
You may qualify if:
- Age ≥18 years
You may not qualify if:
- Inability to give informed consent as documented by signature
- Pregnant or lactating women
- Inability or contraindications to undergo the investigated intervention
- Drugs interfering with blood glucose (e.g. SGLT-2 inhibitors, acarbose) during the time of investigation
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lia Ballylead
- University of Padovacollaborator
Study Sites (1)
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
Bern, Canton of Bern, 3010, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lia Bally, Prof. Dr. med. et phil.
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, lnselspital, Bern University Hospital, University of Bern
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Nutrition, Metabolism and Obesity and Head of Research
Study Record Dates
First Submitted
January 14, 2022
First Posted
January 28, 2022
Study Start
January 18, 2022
Primary Completion
July 26, 2023
Study Completion
July 26, 2023
Last Updated
August 23, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After study completion, 10 years
- Access Criteria
- After written inquiry and approval by the principal investigator.
All IPD that underlie results in a publication will be available to other researchers.